2241 - 2250 of 6230 Results
Title
Year
- Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's disease2022OPENTitle: Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1039214Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1039214/pdfCitation Count: 8
- A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data2021OPENTitle: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.705407Best OA location URL: https://escholarship.org/content/qt2tv8r5dg/qt2tv8r5dg.pdfCitation Count: 61
- ModFus-PD: synergizing cross-modal attention and contrastive learning for enhanced multimodal diagnosis of Parkinson’s disease2025OPENTitle: ModFus-PD: synergizing cross-modal attention and contrastive learning for enhanced multimodal diagnosis of Parkinson’s diseaseJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 19Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2025.1604399Best OA location URL: https://www.frontiersin.org/journals/computational-neuroscience/articles/10.3389/fncom.2025.1604399/pdfCitation Count: 0
- Potential cerebrospinal fluid metabolomic biomarkers and early prediction model for Parkinson’s disease2025OPENTitle: Potential cerebrospinal fluid metabolomic biomarkers and early prediction model for Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2025.1582362Best OA location URL: https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2025.1582362/pdfCitation Count: 0
- Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations2023OPENTitle: Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutationsJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2023.1229213Best OA location URL: https://doi.org/10.3389/fncel.2023.1229213Citation Count: 7
- Association of Family History and Polygenic Risk Score With Longitudinal Prognosis in Parkinson Disease2023OPENTitle: Association of Family History and Polygenic Risk Score With Longitudinal Prognosis in Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200115Best OA location URL: https://www.neurology.org/doi/pdfdirect/10.1212/NXG.0000000000200115Citation Count: 2
-
OPENTitle: Genome Sequencing in the Parkinson Disease ClinicJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/nxg.0000000000200002Best OA location URL: https://ng.neurology.org/content/nng/8/4/e200002.full.pdfCitation Count: 15
-
OPENTitle: Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor SubtypesJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000557Best OA location URL: https://ng.neurology.org/content/nng/7/2/e557.full.pdfCitation Count: 38
- Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s2023OPENTitle: Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’sJournal Name: Journal of Patient-Reported OutcomesPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s41687-023-00577-9Best OA location URL: https://jpro.springeropen.com/counter/pdf/10.1186/s41687-023-00577-9Citation Count: 11
- Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders2023OPENTitle: Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disordersJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-023-01653-3Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-023-01653-3Citation Count: 33